MDAngle

• ASH 2023: Key Insights on Advances in DLBCL   Dr Suchitra Sundaram highlights some of the practice-changing data presented at ASH 2023.
  Medscape, December 15, 2023
• SABCS 2023: Highlights in HR+/HER2- Breast Cancer   Tarah J. Ballinger, MD, provides her biggest takeaways from SABCS 2023 in HR+/HER2- breast cancer.
  Medscape, December 13, 2023
• ASH 2023: Anticipating Impactful Data in DLBCL   Dr Suchitra Sundaram highlights key studies to be presented at ASH 2023.
  Medscape, December 01, 2023
• IKCS 2023: New Data in Metastatic Kidney Cancer   Dr Katy Beckermann reviews new and encouraging data presented at IKCS 2023.
  Medscape, November 29, 2023
• AAO 2023: Clinical Insights From New Data on AMD   Dr Vaidehi Dedania reflects on the impact of AAO 2023 on her patients with age-related macular degeneration.
  Medscape, November 27, 2023
• SABCS 2023: Anticipating New Data in HR+/HER2- Breast Cancer   Tarah J. Ballinger, MD, awaits new updates in HR+/HER2- breast cancer.
  Medscape, November 27, 2023
• AAO 2023: Improving Patients' QOL in Diabetic Macular Edema   Dr Sunir Garg reflects on how highlights from AAO 2023 will affect his patients with diabetic macular edema.
  Medscape, November 20, 2023
• IKCS 2023: New Advances in Metastatic Kidney Cancer   Dr Katy Beckermann highlights a new tyrosine kinase inhibitor and the unique collaborative discussions shaping the future of kidney cancer care, as reported at IKCS 2023.
  Medscape, November 15, 2023
• ESMO 2023: The Impact of New Data on Patient Care   Rana R. McKay, MD, examines new data and AI technology in prostate cancer care at ESMO 2023.
  Medscape, November 13, 2023
• ESMO 2023: Reflecting on New Data in Advanced NSCLC   Julia Rotow, MD, analyzes the latest research presented at ESMO that could impact patient care going forward.
  Medscape, November 13, 2023
• AAO 2023: New Positive Data for Wet AMD   Dr Vaidehi Dedania reviews interesting data presented at AAO 2023 and discusses what's next for age-related macular degeneration.
  Medscape, November 10, 2023
• AAO 2023: Advances in Diabetic Macular Edema Treatment and a Focus on Representation in Clinical Trials   Dr Sunir Garg shares highlights from AAO 2023, including new data on recently approved treatments for diabetic macular edema and papers that addressed racial and ethnic underrepresentation in clinical trials.
  Medscape, November 09, 2023
• IKCS 2023: Anticipating Data Across All of Kidney Cancer   Katy Beckermann, MD, PhD, previews the upcoming IKCS meeting in Nashville, Tennessee.
  Medscape, November 02, 2023
• ESMO 2023: Advancing Prostate Cancer Care   Dr Rana R. McKay offered insights on the practice-changing data presented at ESMO 2023.
  Medscape, October 27, 2023
• ESMO 2023: Key Highlights in Advanced NSCLC   Dr Julia K. Rotow examined the latest breakthroughs in advanced NSCLC as presented at ESMO 2023.
  Medscape, October 27, 2023
• AAO 2023: New Modes of Treatments and New Directions for Diabetic Macular Edema   Dr Sunir Garg outlines several topics to be addressed at AAO 2023, including enhancements to anti-VEGF therapy and strategies for making clinical trials more representative of the general population.
  Medscape, October 27, 2023
• AAO 2023: Anticipating New and Real-World Data in AMD   Dr Vaidehi Dedania looks ahead to the 2023 AAO meeting expecting updates from trials on geographic atrophy as well as clinical best-practices regarding therapies for exudative macular degeneration.
  Medscape, October 27, 2023
• ASTRO 2023: A Trio of Studies With Potential Clinical Implications   Martin T. King, MD, PhD, offers key insights on three studies presented at ASTRO 2023.
  Medscape, October 19, 2023
• ESMO 2023: Anticipating Advances in Prostate Cancer Research   Rana R. McKay, MD, provides a glimpse at the prostate cancer findings that she is excited to see presented at ESMO 2023.
  Medscape, October 12, 2023
• ESMO 2023: Looking Forward to Fresh Data for Advanced NSCLC   Julia Rotow, MD, unpacks the cluster of new data regarding advanced non-small cell lung cancer to be presented at ESMO 2023, emphasizing developments regarding cancers with driver mutations.
  Medscape, October 12, 2023